Martin Waller

When I pick the right share, I shout about it. And here’s what I do when I get it wrong…

The confessions of a newspaper stock tipster

Already a subscriber? Log in

This article is for subscribers only

Subscribe today to get 3 months' delivery of the magazine, as well as online and app access, for only £3.

  • Weekly delivery of the magazine
  • Unlimited access to our website and app
  • Enjoy Spectator newsletters and podcasts
  • Explore our online archive, going back to 1828

I made ten more selections for this year at the start of January. So far, and we have not yet completed the first quarter’s trading, three of them have issued unexpected profit warnings.

As it happens, I believe that of my three failed tips this year, two at least will come good. One is Rolls-Royce, a staggeringly strong company, one of the UK’s best, with an order book of £60 billion or so stretching forward many years.

The other was Centrica, owner of British Gas, to which you probably pay your bills, but with huge oil and gas assets off Brazil and east Africa. After a series of upsets last year, management had assured me, and anyone else prepared to listen, with tears in their eyes that all the bad news was out of the way. It wasn’t.

The third of my dogs was Royal Bank of Scotland, a minuscule proportion of which I own. As do you, through the state’s 83 per cent holding. I took it personally, therefore, when the bank came out with excuses. This one, too, should recover. I chose RBS because banks are heavily exposed to the UK economy, which is clearly on an upwards trend. The more money you, I and businesses have, the more the banks can extract from us all.

I have been doing this job for almost four years and I have only had one complaint against me personally. A very mild email came in saying I had advocated a buy of some misbegotten hi-tech stock, which had promptly collapsed. Would I advise his hanging on for a recovery, or should he cut his losses?

My reply was twofold. One: I am not allowed to give individual advice. I don’t have the qualifications. Two: never heard of the company. Are you sure I told you to buy the shares? Actually, I checked and I hadn’t. It was a colleague filling in for me when I was on holiday.

I will give you one piece of advice, and this is serious. If you have been investing in stocks and shares over the past couple of years, you have been playing the market with loaded dice. This time, though, the dice have been loaded in your favour.

For the past five years or more, governments in this country, the US and elsewhere have been indulging in a massive financial experiment. It goes by the name of quantitative easing because this is seen as more politically acceptable than calling it printing money. Or stealing from savers and pensioners.

The governments have been buying bonds as a way of injecting money into their economies. Bonds are instruments that pay a fixed income as a percentage of their face value. Governments buying them increases their value. This reduces the income holders get when they, too, buy them. If their tradeable value rises, you have to pay more to get at that income.

As the income from those bonds has fallen, investors seeking a return have turned to other assets, in particular shares in quoted companies. And this has pushed up the value of those shares. Logically, therefore, when quantitative easing ends, shares should fall. Almost a year ago the market got a fit of the terrors when Ben Bernanke, then chairman of the Federal Reserve, the US central bank, stated the blindingly obvious: that quantitative easing would indeed end at some point. Prices tumbled, especially on markets in emerging economies. The question no one knows the answer to is how much of that potential fall is already included in share prices at their current level. It is one reason to remain nervous over equities, in my view.

There are plenty of others. The markets seem to suffer from crisis fatigue — they can only focus on one at any time. At present it is Ukraine. But there are other known unknowns. The euro crisis, which has not gone away, the deadlock over the budget in Washington. China, both its economy and military ambitions.

For someone like me who has been watching the market since, ooh, about the South Sea Bubble, there are plenty of reasons to indicate that prices are a bit toppy. We have seen several companies gaining quotes on massive valuations that have not quite got around to the boring business of making a profit. Last time that happened, the dotcom boom of the late 1990s, was just before the last market collapse.

Shares are trading at levels that pre-suppose nothing can go wrong. Professionals like me look at price-earnings ratios. This is a way of correlating share prices to how much the companies actually make. There are any number of perfectly respectable, well-run companies on multiples of 16, 17, 18. This means the market expects profits to remain at their current levels for 16, 17, or 18 years.

This looks a little optimistic. Companies do not disappear in a puff of smoke, unless there has been actual fraud committed. But they do dwindle and die if there are fundamental, unforeseen changes to the markets they serve. Look at the damage Amazon has done to HMV and the like. Somewhere out there are other disruptive technologies, unknown unknowns.

Yachts again. There is an old, apocryphal story of the boss of a successful fund manager showing a guest around and pointing to the marina outside his window. Look at all those yachts, he said. They are all owned by my staff, paid for out of their bonuses. But where, asked the guest, are the clients’ yachts?

Some think the investment community has bought far too many yachts over the past few years, while failing to enrich the people whose funds it looks after. I would tend to agree. But I like to think some readers, if they have taken my advice, might have been able to afford the odd skiff.

Martin Waller edits Tempus, the investment column of the Times, and was last week named financial journalist of the year. His 2013 picks rose by 57 per cent.

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in